Change in Contents of Biologically Active Sphingolipids Modulating Cell Growth and Survival in Hepatoma 27 Compared to Rat Liver

By Kandyba A. G.   Kobliakov V. A.   Somova O. G.   Dyatlovitskaya E. V.  

Biochemistry (Moscow), Vol. 69, Iss. 5, 2004-05 ,pp. : 497-500

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Sphingolipids in tumor metastases and angiogenesis

By Dyatlovitskaya E.   Kandyba A.  

Biochemistry (Moscow), Vol. 71, Iss. 4, 2006-04 ,pp. : 347-353

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Expression of Biologically Active Isoforms of the Tumor Angiogenesis Factor VEGF in Escherichia coli

By Siemeister G.   Schnurr B.   Mohrs K.   Schachtele C.   Marme D.   Martiny-Baron G.  

Biochemical and Biophysical Research Communications, Vol. 222, Iss. 2, 1996-05 ,pp. : 249-255

Elsevier

Access to resources Recommend Favorite

The role of solvent polarity in the mechanism of action of biologically active compounds at ultralow concentrations

By Belov V.   Mal’tseva E.   Pal’mina N.   Burlakova E.  

Doklady Biochemistry & Biophysics, Vol. 399, Iss. 1-6, 2004-11 ,pp. : 362-364

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Proteolytic Fragments of Anti-HIV and Anti-tumor Proteins MAP30 and GAP31 Are Biologically Active

By Huang P.L.   Sun Y.   Chen H-C.   Kung H-F.   Huang P.L.   Lee-Huang S.  

Biochemical and Biophysical Research Communications, Vol. 262, Iss. 3, 1999-09 ,pp. : 615-623

Elsevier

Access to resources Recommend Favorite